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Abstract
Background—In 2012, CDC launched the first federally funded national mass media 
antismoking campaign. The Tips From Former Smokers (Tips) campaign resulted in a 12% 
relative increase in population-level quit attempts.
Purpose—Cost-effectiveness analysis was conducted in 2013 to evaluate Tips from a funding 
agency’s perspective.
Methods—Estimates of sustained cessations; premature deaths averted; undiscounted life years 
(LYs) saved; and quality-adjusted life years (QALYs) gained by Tips were estimated.
Results—Tips saved about 179,099 QALYs and prevented 17,109 premature deaths in the U.S. 
With the campaign cost of roughly $48 million, Tips spent approximately $480 per quitter, $2,819 
per premature death averted, $393 per LY saved, and $268 per QALY gained.
Conclusions—Tips was not only successful at reducing smoking-attributable morbidity and 
mortality but also was a highly cost-effective mass media intervention.
Introduction
Despite declines in cigarette smoking prevalence during the past 50 years, tobacco use 
remains the single most preventable cause of death and disease in the U.S.1,2 Mass media 
campaigns can effectively reduce cigarette use by reducing smoking initiation among youth 
and promoting cessation among adults, particularly when combined with other evidence-
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based tobacco prevention and control interventions.3–8 However, with recent declines in 
public funding for state and local tobacco control programs,9 a critical question is whether 
the economic investments required for these mass media campaigns can be justified by the 
public health benefits.
A few studies3,8,10–16 have estimated the cost effectiveness of state and local campaigns and 
found them to be cost effective. National campaigns can be more economically efficient 
than local campaigns because of economics of scale.17 A few studies18,19 have evaluated the 
cost effectiveness of U.S. national mass media campaigns and also found them to be cost 
effective.
Tips From Former Smokers (Tips), the first federally funded national mass media 
antismoking campaign, launched by CDC, provides a unique opportunity to assess the cost 
effectiveness of a nationwide public health intervention that meets the ad exposure 
recommendation in CDC’s 2014 Best Practices for Comprehensive Tobacco Control 
Programs.20 Funded through the Prevention and Public Health Fund of the Patient 
Protection and Affordable Care Act (2010),21 Tips was on air from March 19 through June 
10, 2012. Ads featured hardhitting, graphic, and emotional testimonials from former 
smokers living with the harsh consequences of smoking-related diseases. Tips ads were 
aimed at increasing public awareness of the immediate and longer-term health damage 
caused by smoking and exposure to secondhand smoke, encouraging smokers to quit, and 
motivating nonsmokers to communicate with family and friends about the dangers of 
smoking. Tips ads were delivered via TV, radio, print (magazines), outdoor (billboards and 
others), theater, and digital media. All ads provided free resources to help quit, including the 
national quitline number (1-800-QUIT-NOW) or a website (www.smokefree.gov).
The 2012 Tips campaign was effective in increasing population-level quit attempts. The 
campaign generated an estimated 1.64 million new quit attempts of ≥ 1 day among U.S. 
adult smokers and approximately 100,000 estimated sustained quits of ≥6 months.22 
Although rough cost-effectiveness estimates were presented in the previous analysis,22 
rigorous cost-effectiveness analyses had yet to be conducted. To address this issue, a cost-
effectiveness analysis was conducted to evaluate the campaign from a funding agency’s 
perspective. Specifically, the cost was assessed based on the campaign-specific expenditure 
administered by CDC, the federal funder of the 2012 Tips. The cost effectiveness of Tips 
was evaluated by four measures: (1) the cost per successful quit; (2) the cost per premature 




The distribution of quitters by gender was calculated over six age groups—18–24, 25–34, 
35–44, 45–54, 55–64, and ≥65 years—from the 2012 GfK KnowledgePanel® survey data 
used to estimate the Tips campaign effect on quit attempts (shown in Appendix Table 
1).22–25 Gains for former smokers who quit in the four age groups from 25 to 64 years were 
estimated using their respective midpoint ages (i.e., 30,40, 50, and 60 years) as the base age 
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for benefit computations. Because survival rates for former smokers who quit before age 30 
years are nearly identical to never smokers,24 survival rates for never smokers were used for 
former smokers who quit at age 18–24 years. Although smokers aged ≥ 65 years may still 
benefit from quitting,26 to be conservative, this analysis did not try to quantify benefits for 
this subpopulation of quitters. For each age and gender group among former smokers aged 
25–64 years, LYs were calculated for former smokers and, counterfactually, for continuing 
smokers, using the appropriate base age as the starting year. For quits in the 18–24-year age 
group, LYs saved were calculated from age 30 years19. QALY gains were calculated from 
published estimates for current and former smokers.27 Both LYs saved and QALYs gained 
were then converted into a net present value using a 3% discount rate.19 Discounting used 
the respective base age for quitters aged 25–64 years; for former smokers aged 18–24 years, 
discounting was applied using a base age of 20 years. QALY gains were then calculated, by 
age and gender group, as total QALYs for former smokers less the total QALYs for a group 
of continuing smokers of the same size.
Premature deaths averted were calculated in a similar way. Working from the number of 
additional quits, the numbers of persons who survive to the projected former-smoker life 
expectancy for each age and gender group at time of quit were estimated for both former 
smokers and an equally sized group of continuing smokers.24,25 Taking the difference 
between the two groups yields the number of premature deaths averted. For age 25–64 
years, this estimate includes all people alive at the respective base age. For quits among the 
18–24-year age group, this estimate includes persons alive at age 30 years. Differences in 
the survival rates between current smokers and never smokers before age 30 years are 
negligible.28
Campaign Costs
Campaign costs were considered from CDC’s perspective. The CDC Office on Smoking and 
Health’s budget for the 2012 Tips was $54,214,962 in 2012 U.S. dollars. Of this, $6,282,153 
was allocated to states for quitline support. Because similar financial support had been 
provided to state quitlines in the fiscal years before the campaign (e.g., $4,772,375 in fiscal 
year 2010), this fund was assumed to still be available if Tips were not in place, and thus 
was not considered part of campaign cost. However, the conclusions of this analysis 
remained unchanged when funding to state quitlines was taken into consideration. 
Consequently, the total attributable cost considered was $47,932,809, of which $6,723,386 
was devoted to creative development and execution; $38,060,582 for media placement (i.e., 
ad buy); and $3,148,841 for evaluation. Evaluation costs are considered an essential 
program cost because the campaign would not be conducted in absence of rigorous 
evaluation research. However, the results of the analysis were not substantially different 
when evaluation costs were excluded. Cost per quit represents the total of the creative 
development, media placement, and evaluation costs, divided by the total number of 
additional quits.
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Confidence Intervals for Premature Deaths Averted, Life Years Saved, and Quality-
Adjusted Life Years Gained
To generate appropriate CIs for these cost-effectiveness measures, a Monte Carlo simulation 
was designed and implemented using TreeAge, version 2013. The simulation used beta 
distributions to generate random outcomes for each age–gender group (12 in all) 
simultaneously for both the as-observed campaign path and for the status-quo counterfactual 
of no campaign at two points for each group: (1) whether or not to attempt to quit and (2) 
whether or not to become a sustained quitter of ≥6 months.
In the simulation, the 6-month sustained quit rate was derived from the estimated 100,000 
sustained quits reported in McAfee et al. (Figure 1).22,23 This estimate is derived by 
combining external estimates of long-term smoking relapse with primary survey-based 
estimates of post-campaign cigarette abstinence rates. Figure 2 illustrates a detailed decision 
tree that shows the application of the 6.1% successful quit rate to those who attempted to 
quit under each scenario (campaign versus no campaign).
Parameters for the beta distributions were derived from the estimated size of the adult 
smoker cohort; its distribution by age and gender, estimated attempts to quit, and the 
distributions of quits are summarized in Appendix Table 2. Because the simulation was 
designed to vary the number of quit attempts and successful quits, benefits (including 
premature deaths averted, LYs saved, and QALYs gained) were input into the simulation as 
a per-quit value.
The primary analysis was based on a simulation with randomly selected per-quit benefits of 
premature death averted, LYs saved, and QALYs gained from uniform distributions based 
on the two recently published estimates on life expectancy described above as the 
extrema.24,25 Additionally, two independent analyses were conducted using the lower or 
upper bounds of the distributions for each age group, gender, and benefit category, 
respectively.24,25 The ranges of the distributions, as well as the lower and upper bound 
inputs of these per-quit benefits, are reported in Appendix Table 2. Each simulation was 
repeated 100,000 times to generate CIs. Cost-effectiveness measures were calculated at 
runtime of each simulation, using fixed values for total costs.
Sensitivity Analyses
Because the choice of the discount rate can have a significant impact on the net present 
values of LY saved and QALYs gained, sensitivity analyses were conducted based on 0%, 
1%, and 5% discount rates, in addition to the 3% discount rates used in the main analysis.
As the campaign generated benefits by inducing additional quit attempts, determining how 
the composition of the quit attempter population affects the outcome variables of interest 
(i.e., quits, deaths averted, discounted QALYs, and discounted life years) is important. 
Therefore, these outcome variables were regressed on separate variables for quit attempts by 
each age group and gender and from both campaign and status quo scenarios (24 
independent variables in total), using a log–log ordinary least squares specification. The 
results showed that the simulation output was most responsive to changes in quit attempts by 
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women aged 18–24 and 25–34 years, and men aged 25–34 years. The full results are also 
presented in Appendix Table 3.
Finally, a sensitivity analysis was conducted, depicting the effect of reducing the Tips 
impact on successful quits by half to assess the robustness of the findings.22 These results 
are presented in Appendix Tables 4 and 5.
Results
Based on the 6.1% sustained quit rate derived from McAfee and colleagues,22 Table 1 
presents the results and CIs estimated from three simulations on campaign-attributable 
sustained quitters, premature deaths averted, LYs saved, and QALYs gained among U.S. 
adult smokers. In the simulation with randomized benefits, stemming from 100,000 (95% 
CI=95,592–104,409) additional campaign-attributable sustained quitters (Figure 1), Tips 
contributed to approximately 17,109 (CI=15,412–18,806) additional premature deaths 
averted; 122,136 (CI=111,121–133,151) additional discounted LYs saved; and 179,099 
(CI=165,436–192,762) additional discounted QALYs gained or 1.79 (CI=1.68–1.90) 
QALYs per induced quit.
In the simulation with lower-bound benefits, Tips contributed to approximately 13,638 
(CI=12,988–14,289) additional premature deaths averted; 98,676 (CI=93,704–103,648) 
additional discounted LYs saved; and 154,382 (CI=147,015–161,750) additional discounted 
QALYs gained or 1.54 (CI=1.52–1.57) QALYs per induced quit. Alternatively, the 
simulation with upper-bound benefits suggested that around 22,099 (CI=21,081–23,116) 
additional premature deaths were averted; 145,578 (CI=138,116–153,040) additional 
discounted LYs were saved; and 203,804 (CI=193,993–213,614) additional discounted 
QALYs were gained or 2.04 (CI=2.00–2.08) QALYs per induced quit were obtained 
because of Tips.
The average campaign cost per additional sustained quitter was approximately $480 (CI=
$460–$500) (Table 2). In the randomized simulation, the average campaign cost was 
estimated around $2,820 (CI= $2,550–$3,090) per additional premature death averted; $390 
(CI=$360–$430) per attributable LY saved; and $270 (CI=$250–$290) per additional QALY 
gained. In the lower-bound simulation, these were estimated around $3,510 (CI=$3,340–
$3,680) per additional premature death averted; $490 (CI=$460–$510) per attributable LY 
saved; and $310 (CI=$300–$330) per additional QALY gained. The upper-bound simulation 
estimated around $2,220 (CI=$2,120–$2,330) per additional premature death averted; $330 
(CI=$310–$350) per attributable LY saved; and $240 (CI=$220–$250) per additional QALY 
gained.
These cost-effectiveness measures were also obtained at median as well as at 2.5 and 97.5 
percentiles of the distribution through the simulation to assess the robustness of the mean 
estimates. These estimates were very comparable to the main findings reported above.
In the randomized simulation (Table 3), the average cost per additional LY saved was $180 
(CI=$160–$190) without discounting; $240 (CI=$220–$260) at 1% discounting; or $580 
(CI=$500–$660) at 5% discounting. Based on the same simulation (Table 4), the average 
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cost per additional QALY gained was $120 (CI=$110–$130) without any discount; $150 
(CI=$140–$160) at 1% discounting; or $390 (CI=$360–$420) at 5% discounting. Similar 
estimates were also obtained based on the lower-and upper-bound simulations. Generally, 
the patterns of these estimates were very consistent with the findings from the randomized 
simulation, suggesting that the cost effectiveness of the Tips campaign might range from 
$100 to $460 per QALY gained.
Under the unlikely scenario assuming only half of the estimated additional sustained quits 
were Tips attributable, the average costs were estimated around $960 (CI=$920–$1,000) per 
additional quitter, $5,620 (CI=$5,060–$6,180) per additional premature death averted, $790 
(CI=$720–$860) per attributable LY saved, and $540 (CI=$500–$580) per additional QALY 
gained in the randomized simulation (Appendix Tables 4 and 5).
Discussion
With total campaign expenditures of about $48 million, Tips spent approximately $480 per 
quitter, $2,820 per premature death averted, $390 per LY saved, and $270 per QALY 
gained. These results compare favorably with other smoking interventions, such as the EX 
and truth® campaigns.18,19 For example, when the EX campaign was analyzed from the 
program perspective using the same QALY per quitter ratio (1.79 per induced quit) as the 
Tips campaign, the cost per quitter is roughly $9,550 in 2012 dollars and the cost per QALY 
is $5,330.19 An analysis of the truth® campaign from the program perspective revealed a 
cost per QALY of around $1,420.18 These comparisons should be interpreted with caution 
owing to differences in campaign delivery (EX was delivered with less media intensity) and 
target audience (the truth® campaign focused on youth) as well as in analytic approach and 
study assumptions.
In the U.S., a commonly used but arbitrary threshold to consider an intervention to be cost 
effective from a societal perspective is $50,000 per LY or QALY gained.29 This study does 
not include information on other societal costs associated with Tips. Other campaign 
evaluations19 assessed that under a very generous scenario, any attempted quitters receiving 
help were assumed to utilize four counseling sessions for one quit attempt, a 12-week course 
of nicotine replacement therapy or prescriptions with brand-name medications, or both. In 
this case, for every dollar invested in a mass media campaign, an additional $7.30 could be 
spent for these evidence-based cessation treatments. This ratio would suggest that the 
absolute ceiling for total societal costs of Tips is $2,847 per LY saved or $1,971 per QALY 
gained, which is still 15 times less than the $50,000 per QALY benchmark. Alternatively, 
according to the WHO’s recommendation, an intervention is considered highly cost 
effective if it is less than the country’s per capita gross domestic product (GDP) per LY 
saved.30 With this threshold and U.S. per capita GDP in 2012 (approximately $51,700),31,32 
Tips is also a highly cost-effective intervention.
This analysis has several limitations. First, the costs in this analysis are estimated from a 
funding agency’s perspective. Therefore, the additional costs that might be incurred by 
quitters who are aided in their quit attempts by physicians, counseling groups, or 
pharmacotherapy are not included. However, benefits, including averted medical costs or 
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increased productivity of smokers who quit, are also not included. Second, the analysis does 
not consider possible switching behaviors between cigarettes and other combustible or non-
combustible tobacco products among quitters. However, this is very rare (0.3% in the past 
12 months) for smokers switching to smokeless tobacco.33 A third limitation is that this 
study is based on the estimated campaign-attributable successful quits that last ≥6 months. 
Although the original estimate of sustained quits due to the Tips campaign was conservative 
for several reasons,22 it is possible that the cost-effectiveness results will be overstated if 
additional relapses occurred after 6 months. However, the sensitivity analysis shows that 
Tips is cost effective, even if its effects were reduced by half.22 Finally, estimates of the 
population impact of the Tips campaign are based on an online sample of smokers from 
KnowledgePanel.22 Although this sample is based on probability sampling methods, it may 
differ from the U.S. smoking population as a whole. However, no substantial evidence of 
bias in the sample characteristics was found. For example, 77.7% of current smokers in the 
KnowledgePanel survey were daily smokers in 2012 compared to 78.4% of current smokers 
in the 2012 National Health Interview Survey. In addition, several recent studies in the 
survey methodology literature have shown that KnowledgePanel data are equally or more 
comparable to Census benchmarks as other types of probability-based samples including 
random-digit-dial telephone surveys.34
The estimates of program benefits are conservative in at least five ways. First, although the 
analysis assumes that the campaign raised the number of quit attempts, the possibility that 
the campaign also increased the success rates of quit attempts is not considered. In addition, 
estimates of the campaign-attributable increase in the number of quit attempts are based on 
two-tailed statistical tests, which allowed for the possibility that the campaign could have 
decreased the quit attempt rate. Third, the impact of the campaign on smoking initiation 
among adolescents and young adults is not considered and the impacts of reducing 
secondhand exposure related to quits are not considered. Fourth, to be conservative, the 
health benefits to campaign-attributable quitters aged ≥65 years are not included in the 
analysis. Finally, only immediate cessation effects are measured and do not capture any 
long-term impact of Tips on future post-campaign quit attempts.
Policymakers, public health officials, and clinicians face limited resources as they work to 
reduce the enormous human and financial toll of tobacco use. It is therefore important to 
identify interventions that have a large impact at a relatively small cost. These findings 
suggest that a national, federally funded mass media campaign can be highly cost effective 
to reduce the burden of tobacco use. These findings may also be useful to policymakers in 
other countries when they consider population-based mass media anti-tobacco campaigns 
similar to Tips.35
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Long-term successful quits as a result of the Tips campaign.
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Decision tree for impact of the 2012 Tips campaign on successful quits.
aSee Figure 1 for derivation of estimated 6.1% successful quit rate as reported in McAfee et 
al.22
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Table 1









Campaign-attributable quits 100,000 (95,592–104,409) 100,000 (95,592–104,409) 100,000 (95,592–104,409)
Additional premature deaths averted 13,638 (12,988–14,289) 17,109 (15,412–18,806) 22,099 (21,081–23,116)
Additional LYs saved 98,676 (93,704–228,182) 122,136 (111,121–133,151) 145,578 (138,116–153,040)
Additional QALYs gained 154,382 (147,015–161,750) 179,099 (165,436–192,762) 203,804 (193,993–213,614)
QALYs per induced quit 1.54 (1.52–1.57) 1.79 (1.68–1.90) 2.04 (2.00–2.08)
LY, life year; QALY, quality-adjusted life year.
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Table 2








Cost per quit $480 ($460–$500) $480 ($460–$500) $480 ($460–$500)
Cost per premature death averted $3,510 ($3,340–$3,680) $2,820 ($2,550–$3,090) $2,220 ($2,120–$2,330)
Cost per LY saved $490 ($460–$510) $390 ($360–$430) $330 ($310–$350)
Cost per QALY gained $310 ($300–$330) $270 ($250–$290) $240 ($220–$250)
Note: The numbers shown here are rounded to the nearest $10.
LY, life year; QALY, quality-adjusted life year.
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